ArticleESMO open2022

Letter comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of patients with metastatic breast cancer.

Kadri AltundagPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.